4//SEC Filing
RAY DEBANJAN 4
Accession 0001567619-18-003477
CIK 0001501989other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 3:18 PM ET
Size
8.3 KB
Accession
0001567619-18-003477
Insider Transaction Report
Form 4
RAY DEBANJAN
Chief Financial Officer
Transactions
- Sale
Common Stock
2018-10-01$18.46/sh−3,000$55,380→ 5,928 total - Exercise/Conversion
Common Stock
2018-10-01$1.45/sh+3,000$4,347→ 8,928 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-10-01−3,000→ 13,220 totalExercise: $1.45Exp: 2024-02-27→ Common Stock (3,000 underlying)
Footnotes (2)
- [F1]The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- [F2]100% of the shares subject to the option are fully vested and exercisable.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001706863
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 3:18 PM ET
- Size
- 8.3 KB